Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease
Huikuan Chu, Yi Duan, Ling Yang, et al.
Gut (2018) Vol. 68, Iss. 2, pp. 359-370
Open Access | Times Cited: 304

Showing 51-75 of 304 citing articles:

Dietary fiber intake and non-alcoholic fatty liver disease: The mediating role of obesity
Yu Zhu, Yang Hu, Yaozong Zhang, et al.
Frontiers in Public Health (2023) Vol. 10
Open Access | Times Cited: 25
The pathophysiology of MASLD: an immunometabolic perspective
Julian Schwärzler, Felix Grabherr, Christoph Grander, et al.
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 4, pp. 375-386
Closed Access | Times Cited: 25
SAÚDE PÚBLICA: EPIDEMIOLOGIA, CLÍNICA E ESTRATÉGIAS DE TRATAMENTO
Carla Patrícia de Carvalho Oliveira, Avelar Alves da Silva, Paulo Sérgio da Paz Silva Filho, et al.
(2023)
Open Access | Times Cited: 24
A microbial metabolite inhibits the HIF-2α-ceramide pathway to mediate the beneficial effects of time-restricted feeding on MASH
Yi Zhang, Xuemei Wang, Jun Lin, et al.
Cell Metabolism (2024) Vol. 36, Iss. 8, pp. 1823-1838.e6
Closed Access | Times Cited: 8
Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma
Jia Wang, Cynthia Rajani, Hong‐Xi Xu, et al.
Protein & Cell (2020) Vol. 12, Iss. 5, pp. 374-393
Open Access | Times Cited: 67
Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats
Zehua Zhao, Feng‐Zhi Xin, Da Zhou, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 20, pp. 2450-2462
Open Access | Times Cited: 66
Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
Xiaofan Jiang, Juan Zheng, Shixiu Zhang, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 64
A Review of Non-Alcoholic Fatty Liver Disease in HIV-Infected Patients: The Next Big Thing?
Berend J. van Welzen, Tania Mudrikova, Ayman El Idrissi, et al.
Infectious Diseases and Therapy (2019) Vol. 8, Iss. 1, pp. 33-50
Open Access | Times Cited: 63
Characterization of the immune cell landscape of patients with NAFLD
Tom Diedrich, Silke Kummer, Antonio Galante, et al.
PLoS ONE (2020) Vol. 15, Iss. 3, pp. e0230307-e0230307
Open Access | Times Cited: 61
Deep-DRM: a computational method for identifying disease-related metabolites based on graph deep learning approaches
Tianyi Zhao, Yang Hu, Liang Cheng
Briefings in Bioinformatics (2020) Vol. 22, Iss. 4
Closed Access | Times Cited: 61
Maternal sucralose intake alters gut microbiota of offspring and exacerbates hepatic steatosis in adulthood
Xin Dai, Zixuan Guo, Danfeng Chen, et al.
Gut Microbes (2020) Vol. 11, Iss. 4, pp. 1043-1063
Open Access | Times Cited: 56
Turnover of bile acids in liver, serum and caecal content by high-fat diet feeding affects hepatic steatosis in rats
Yingyue Tang, Jingyi Zhang, Jing Li, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2019) Vol. 1864, Iss. 10, pp. 1293-1304
Closed Access | Times Cited: 54
Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASH
Gianluca Svegliati‐Baroni, Bárbara G. Patrício, Gessica Lioci, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5820-5820
Open Access | Times Cited: 53
Gut microbiota and systemic immunity in health and disease
Bernard C. Lo, Grace Chen, Gabriel Núñez, et al.
International Immunology (2020) Vol. 33, Iss. 4, pp. 197-209
Open Access | Times Cited: 53
A high-fat diet and high-fat and high-cholesterol diet may affect glucose and lipid metabolism differentially through gut microbiota in mice
Huijing Liang, Fengling Jiang, Ruyue Cheng, et al.
EXPERIMENTAL ANIMALS (2020) Vol. 70, Iss. 1, pp. 73-83
Open Access | Times Cited: 51
Hypoxia: The “Invisible Pusher” of Gut Microbiota
Ni Han, Zhiyuan Pan, Guangwei Liu, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 44
Aryl Hydrocarbon Receptor Deficiency in Intestinal Epithelial Cells Aggravates Alcohol-Related Liver Disease
Minyi Qian, Jun Liu, Danyang Zhao, et al.
Cellular and Molecular Gastroenterology and Hepatology (2021) Vol. 13, Iss. 1, pp. 233-256
Open Access | Times Cited: 44
Novel β-mannanase/GLP-1 fusion peptide high effectively ameliorates obesity in a mouse model by modifying balance of gut microbiota
Yan Wang, Nuraliya Ablimit, Yunpeng Zhang, et al.
International Journal of Biological Macromolecules (2021) Vol. 191, pp. 753-763
Closed Access | Times Cited: 41
Anti-obesity natural products and gut microbiota
Shang‐Zhen Li, Su-Ling Zeng, E‐Hu Liu
Food Research International (2021) Vol. 151, pp. 110819-110819
Closed Access | Times Cited: 41
Targeting Gut Microbiota With Natural Polysaccharides: Effective Interventions Against High-Fat Diet-Induced Metabolic Diseases
Chao‐Yue Sun, Zuo-Liang Zheng, Cunwu Chen, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 34
The ameliorative effect of probiotics on diet-induced lipid metabolism disorders: A review
Yu Wang, Zhiyi Ai, Xinyue Xing, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 64, Iss. 11, pp. 3556-3572
Closed Access | Times Cited: 34
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Potentilla discolor Bunge
Longshan Ji, Qian Li, Yong He, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 9, pp. 3529-3547
Open Access | Times Cited: 27
Cultivated Enterococcus faecium B6 from children with obesity promotes nonalcoholic fatty liver disease by the bioactive metabolite tyramine
Jia Wang, Jiayou Luo, Fei Yang, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 6
Multi-omics reveals the mechanism of Trimethylamine N-oxide derived from gut microbiota inducing liver fatty of dairy cows
Chenlei Li, Feifei Wang, Yongxia Mao, et al.
BMC Genomics (2025) Vol. 26, Iss. 1
Open Access
Pharmacological treatment for metabolic dysfunction–associated steatotic liver disease and related disorders: Current and emerging therapeutic options
Xiang Zhang, Harry Cheuk-Hay Lau, Jun Yu
Pharmacological Reviews (2025) Vol. 77, Iss. 2, pp. 100018-100018
Open Access

Scroll to top